Arumugam Balamurugan

Author

University of California, Los Angeles ORCID

Also Known As

A Balamurugan, A. Balamurugan, Arumugam Balamurugan, Balamurugan A R, Balamurugan Arumugam, Sosale R Aravind

Publications

Citations

H-Index

Concepts

All Affiliations

University of California, Los Angeles All India Institute of Medical Sciences Black AIDS Institute Broad Center Stanford University

About

Arumugam Balamurugan is an author at University of California, Los Angeles specializing in medicine, immunology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	758
2	Public Health	2	2	404
3	Education	1	1	154
4	Language Studies	1	1	154
5	Natural Sciences	1	1	63

Arumugam Balamurugan

Publications

Citations

H-Index

Page 1

	Year	Citations
Evaluation of Clinical and Immunogenetic Risk Factors for the Development of Hepatotoxicity during Antituberculosis Treatment Surendra K. Sharma, Arumugam Balamurugan, Pradip Kumar Saha, American Journal of Respiratory and Critical Care Medicine ImmunologyGenetic EpidemiologyPathologyClinical Risk FactorsAntituberculosis Treatment	2002	333
Gene therapy for adenosine deaminase–deficient severe combined immune deficiency: clinical comparison of retroviral vectors and treatment plans Fabio Candotti, Kit L. Shaw, Linda Muul, Blood	2012	233
Distinctive KIR and HLA diversity in a panel of north Indian Hindus Raja Rajalingam, Peter Krausa, Heather Shilling, Immunogenetics HinduismEthnicityHla DiversityNorth Indian HindusSouth Asian Culture	2002	154
A highly efficient short hairpin RNA potently down-regulates CCR5 expression in systemic lymphoid organs in the hu-BLT mouse model Saki Shimizu, Patrick Hong, Arumugam Balamurugan, Blood	2009	150
Cytokine Polarization in Miliary and Pleural Tuberculosis Surendra K. Sharma, Dipender Kumar Mitra, Arumugam Balamurugan, Journal of Clinical Immunology	2002	123
Primary, Recall, and Decay Kinetics of SARS-CoV-2 Vaccine Antibody Responses F. Javier Ibarrondo, Christian Hofmann, Jennifer A. Fulcher, ACS Nano ImmunodeficienciesImmunologyImmunodominanceVaccine-induced Antibody LevelsCovid-19	2021	87
In Vivo Suppression of HIV by Antigen Specific T Cells Derived from Engineered Hematopoietic Stem Cells Scott G. Kitchen, Bernard Levin, Gregory Bristol, PLoS Pathogens Cell TherapyVivo SuppressionT-regulatory CellImmunologyImmunodominance	2012	83
Human Immunodeficiency Virus Type 1 Clade B Superinfection: Evidence for Differential Immune Containment of Distinct Clade B Strains Otto O. Yang, Eric S. Daar, Beth D. Jamieson, Journal of Virology	2004	83
Clinical efficacy of gene-modified stem cells in adenosine deaminase–deficient immunodeficiency Kit L. Shaw, Elizabeth Garabedian, Suparna Mishra, Journal of Clinical Investigation	2017	79
Clinical and genetic risk factors for the development of multi-drug resistant tuberculosis in non-HIV infected patients at a tertiary care center in India: a case-control study Surendra K. Sharma, Kiran K. Turaga, Arumugam Balamurugan, Infection Genetics and Evolution Multi-drug Resistant TuberculosisPulmonary TuberculosisMedicineTuberculosis PreventionClinical Epidemiology	2003	71

Page 1